Scavilla Daniel T
President, CEO at GMED
- Sold, on record
- $34.2M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Nov 21, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- GMEDGLOBUS MEDICAL INCPresident, CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale GMEDUnusualApr 10, 2018 2018
Sold 100,000 shares at $50.00 ($5M)
Scavilla Daniel T, Senior VP and CFO
Sold 100% of holdings ($5M position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale GMEDUnusualMay 21, 2020 +772 days
Sold 100,000 shares at $55.09 ($5.5M)
Scavilla Daniel T, EVP, Chief Commercial Officer
Sold 100% of holdings ($5.5M position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale GMEDUnusualJul 2, 2021 +407 days
Sold 100,000 shares at $78.41 ($7.8M)
Scavilla Daniel T, EVP, Chief Commercial Officer
Sold 100% of holdings ($7.8M position)0 shares leftFiling
- 4 Form 144 notice GMEDNoticeNov 6, 2024 +1223 days
Filed to sell 60,000 shares ($4.8M)
Scavilla Daniel T, Officer, Director
10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale GMEDRoutineNov 6, 2024 same day
Sold 60,000 shares at $80.02 ($4.8M)
Scavilla Daniel T, President, CEO
10b5-1 planSold 100% of holdings ($4.8M position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 notice GMEDNoticeNov 21, 2024 +15 days
Filed to sell 130,000 shares ($11M)
Scavilla Daniel T, Officer
10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale GMEDRoutineNov 21, 2024 same day
Sold 130,000 shares at $85.00 ($11.1M)
Scavilla Daniel T, President, CEO
10b5-1 planSold 100% of holdings ($11.1M position)0 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Nov 25, 2024 | GMED | President, CEO | Form 4 sale | 130,000 | $11.1M | 100.0% | Routine | SEC |
| Nov 21, 2024 | Nov 21, 2024 | GMED | Officer | Form 144 notice | 130,000 | $11M | Notice | SEC | |
| Nov 6, 2024 | Nov 8, 2024 | GMED | President, CEO | Form 4 sale | 60,000 | $4.8M | 100.0% | Routine | SEC |
| Nov 6, 2024 | Nov 6, 2024 | GMED | Officer, Director | Form 144 notice | 60,000 | $4.8M | Notice | SEC | |
| Jul 2, 2021 | Jul 7, 2021 | GMED | EVP, Chief Commercial Officer | Form 4 sale | 100,000 | $7.8M | 100.0% | Unusual | SEC |
| May 21, 2020 | May 26, 2020 | GMED | EVP, Chief Commercial Officer | Form 4 sale | 100,000 | $5.5M | 100.0% | Unusual | SEC |
| Apr 10, 2018 | Apr 11, 2018 | GMED | Senior VP and CFO | Form 4 sale | 100,000 | $5M | 100.0% | Unusual | SEC |